Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S W Flatt

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal of the American Dietetic Association|October 19, 1999
Factors associated with weight gain in women after diagnosis of breast cancer. Women's Healthy Eating and Living Study GroupC L Rock, S W Flatt, V Newman, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|October 15, 2003
Correlates of obesity in postmenopausal women with breast cancer: comparison of genetic, demographic, disease-related, life history and dietary factorsL Wasserman, S W Flatt, L Natarajan, et al.
Journal of Obesity & Weight Loss Therapy|April 10, 2018
Factors Associated with Visceral Fat Loss in Response to a Multifaceted Weight Loss InterventionF X Liu, S W Flatt, J F Nichols, et al.
Nutrition and Cancer|January 1, 1997
Feasibility of a randomized trial of a high-vegetable diet to prevent breast cancer recurrenceJ P Pierce, S Faerber, F A Wright, et al.
The International Journal of Eating Disorders|February 5, 2000
Eating pathology and obesity in women at risk for breast cancer recurrenceC L Rock, A J McEligot, S W Flatt, et al.
Cancer|January 10, 2001
Reduction in fat intake is not associated with weight loss in most women after breast cancer diagnosis: evidence from a randomized controlled trialC L Rock, C Thomson, B J Caan, et al.
Clinical Pharmacology and Therapeutics|March 25, 2011
Tamoxifen metabolite concentrations, CYP2D6 genotype, and breast cancer outcomesL Madlensky, L Natarajan, S Tchu, et al.
Breast Cancer Research and Treatment|December 23, 2016
An Antiestrogenic Activity Score for tamoxifen and its metabolites is associated with breast cancer outcomeA H M de Vries Schultink, X Alexi, E van Werkhoven, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of the American Dietetic Association|October 19, 1999
Factors associated with weight gain in women after diagnosis of breast cancer. Women's Healthy Eating and Living Study GroupC L Rock, S W Flatt, V Newman, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|October 15, 2003
Correlates of obesity in postmenopausal women with breast cancer: comparison of genetic, demographic, disease-related, life history and dietary factorsL Wasserman, S W Flatt, L Natarajan, et al.
Journal of Obesity & Weight Loss Therapy|April 10, 2018
Factors Associated with Visceral Fat Loss in Response to a Multifaceted Weight Loss InterventionF X Liu, S W Flatt, J F Nichols, et al.
Nutrition and Cancer|January 1, 1997
Feasibility of a randomized trial of a high-vegetable diet to prevent breast cancer recurrenceJ P Pierce, S Faerber, F A Wright, et al.
The International Journal of Eating Disorders|February 5, 2000
Eating pathology and obesity in women at risk for breast cancer recurrenceC L Rock, A J McEligot, S W Flatt, et al.
Cancer|January 10, 2001
Reduction in fat intake is not associated with weight loss in most women after breast cancer diagnosis: evidence from a randomized controlled trialC L Rock, C Thomson, B J Caan, et al.
Clinical Pharmacology and Therapeutics|March 25, 2011
Tamoxifen metabolite concentrations, CYP2D6 genotype, and breast cancer outcomesL Madlensky, L Natarajan, S Tchu, et al.
Breast Cancer Research and Treatment|December 23, 2016
An Antiestrogenic Activity Score for tamoxifen and its metabolites is associated with breast cancer outcomeA H M de Vries Schultink, X Alexi, E van Werkhoven, et al.
Pageof 2